Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Classical hematology 2

Conditions

Anemia 6Colorectal Neoplasms 3Anemia, Iron-Deficiency 3Postoperative Complications 2Neoplasms 2Adenocarcinoma 2Pancreatic Neoplasms 1Lymphoproliferative Disorders 1Inflammatory Breast Neoplasms 1Carcinoma, Ductal, Breast 1

Interventions

Gemcitabine 27Fluorouracil 25Oxaliplatin 21Cisplatin 19Leucovorin 17Bevacizumab 15130-nm albumin-bound paclitaxel 13Docetaxel 12Capecitabine 12Albumin-Bound Paclitaxel 12Paclitaxel 11Irinotecan 10Carboplatin 9pembrolizumab 7Radiotherapy 6Pemetrexed 6Nivolumab 6Erlotinib Hydrochloride 6Cyclophosphamide 6Trastuzumab 5Ramucirumab 5Ipilimumab 4Everolimus 4Crizotinib 4Cetuximab 4vandetanib 3trastuzumab deruxtecan 3sargramostim 3folfirinox 3Sorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma × ferric carboxymaltose × Clear all
NCT01701310 2016-10-28

IVICA

Nottingham University Hospitals NHS Trust

Phase 4 Completed
116 enrolled
Classical hematologyGastrointestinal

Adenocarcinoma, Anemia, Postoperative Complications, Colorectal Neoplasms

NCT02057471 2014-02-07

Intravenous Iron: Measuring Response in Anemic Surgical Patients

Nottingham University Hospitals NHS Trust

Phase 4 Completed
20 enrolled
Classical hematologyGastrointestinal

Adenocarcinoma, Anemia, Postoperative Complications, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡